Skip to main content
Fig. 2 | BMC Infectious Diseases

Fig. 2

From: The efficacy of paritaprevir/ritonavir/ombitasvir+dasabuvir and ledipasvir/sofosbuvir is comparable in patients who failed interferon-based treatment with first generation protease inhibitors - a multicenter cohort study

Fig. 2

Treatment outcome. End of treatment virologic response (EOT-VR) and sustained virologic response (SVR) rate; ITT—intent-to-treat analysis, which included all patients receiving at least 1 dose of the treatment, mITT—modified ITT analysis, which excluded patients with missing data of sustained virologic response (at least 12 weeks after treatment completion)

Back to article page

BMC Infectious Diseases

ISSN: 1471-2334

Contact us